TZAP靶向GNT-V调控鼻咽癌细胞增殖和干性的研究
批准号:
82060500
项目类别:
地区科学基金项目
资助金额:
35.0 万元
负责人:
肖胜军
依托单位:
学科分类:
肿瘤治疗抵抗
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
肖胜军
中文摘要
肿瘤干细胞的治疗抗性是肿瘤复发和转移的根源,寻找有效抑制癌干性的靶点对提高其疗效至关重要。我们前期发现,TZAP在鼻咽癌组织中表达下调且与进展期临床病理特征相关;TZAP负向调控鼻咽癌细胞增殖,TZAP敲除显著增强鼻咽癌细胞干性;癌基因GNT-V(GV)的转录受转录因子TZAP负向调控,GV过表达促进鼻咽癌细胞增殖。据此提出TZAP靶向GV调控鼻咽癌细胞增殖、干性和放疗敏感性的假说。本项目拟进一步阐明TZAP和GV对鼻咽癌细胞增殖、干性和放疗敏感性的影响,并确证GV是否介导了TZAP的功能;采用RNA seq揭示TZAP过表达或敲除后的鼻咽癌细胞的基因表达谱,预测TZAP参与相关调控的机制与调控网络,并进行功能验证。最后评价GV抑制剂单药或联合放疗的体内抑瘤效果;临床标本验证TZAP、GV与干性相关基因和辐射抗性基因表达的相关性及临床病理意义。预期成果将为寻找鼻咽癌新的治疗靶点提供依据。
英文摘要
Therapeutic resistances of cancer stem cells stand at the root of tumor recurrence and metastasis. Exploring effective targets to suppress cancer stemness is essential to improve therapeutic efficacy of malignancies. Previously, we found that TZAP downregulated in nasopharyngeal carcinoma (NPC) tissues and downregulated TZAP associated with advanced clinicopathological characters. In vitro analysis showed that TZAP negatively modulated proliferation and stemness of NPC cells. In addition, the transcription of GNT-V was negatively modulated by transcriptional factor TZAP. Overexpression of GNT-V promoted the proliferation of NPC cells. Thus, the hypothesis of TZAP targeting GNT-V to regulate proliferation, stemness and radiosensitivity of NPC cells was proposed. This project aims to further elucidate the effects of TZAP and GNT-V on proliferation, stemness and radiosensitivity of NPC and to confirm whether GNT-V mediated the function of TZAP. RNA sequence would be used to reveal gene expression profiles in TZAP overexpressed or knockout NPC cells. The mechanisms and regulatory networks involved in TZAP-related regulation would be predicted, and functional validation be performed. Finally, tumor suppression effect of GNT-V inhibitor monotherapy or combined radiotherapy in vivo would be evaluated. Expression of TZAP, GNT-V, stemness related gene and radiation resistance associated gene would be detected in clinical pathological tissues and their clinicopathological significance would be explored. The expected results will provide a basis for finding new therapeutic targets for NPC.
鼻咽癌是一种起源于鼻咽黏膜的恶性肿瘤,具有较高的发病率和死亡率。本研究旨在探讨TZAP在鼻咽癌中的表达谱、功能及其调控机制,以期为鼻咽癌的治疗提供新的靶点。研究首先分析了TZAP在鼻咽癌临床组织标本中的表达谱。结果显示,TZAP在鼻咽癌组织中的表达显著下调,并且其表达与肿瘤T分期、颈部淋巴结转移、远处转移及临床分期呈负相关,提示TZAP可能在鼻咽癌中发挥抑瘤基因的功能。进一步研究发现,TZAP的过表达能够显著抑制鼻咽癌细胞的体内外增殖,而TZAP的干扰则会促进细胞增殖。此外,TZAP过表达还抑制了细胞的迁移和侵袭能力,而TZAP的干扰则增强了这些能力。这表明TZAP对鼻咽癌细胞的增殖、迁移和侵袭具有重要的调控作用。在机制研究中,GNT-V被鉴定为TZAP的下游关键基因,并部分介导了TZAP的功能。实验表明,TZAP的过表达抑制了GNT-V的表达,而TZAP的敲除则导致GNT-V表达上调,提示GNT-V可能参与了TZAP对鼻咽癌细胞增殖、迁移和侵袭的调控。最后,研究还探讨了鼻咽癌组织中TZAP表达下调的调控机制。结果发现,启动子区DNA甲基化并非TZAP在鼻咽癌组织中表达下调的原因。相反,EBV编码的miRNA EBV-miR-BART8-5p通过与TZAP mRNA的3'-UTR区互补配对负向调控TZAP表达,是鼻咽癌组织中TZAP表达下调的原因之一。综上所述,本研究揭示了TZAP在鼻咽癌中的表达下调及其对细胞增殖、迁移和侵袭的调控作用,并初步探讨了其调控机制。这些发现为鼻咽癌的分子机制研究提供了新的视角,并为开发新的治疗策略提供了潜在的靶点。
国内基金
海外基金